Medpace Holdings, Inc. (MEDP)

395.93 +6.16 (+1.58%) 收市：04:00PM EDT

Medpace Holdings, Inc.

5375 Medpace Way
Cincinnati, OH 45227
United States
513 579 9911
https://www.medpace.com

版塊: Healthcare
行業: Diagnostics & Research
全職員工: 5,800

高階主管

名稱	頭銜	支付	行使價	出生年份
Dr. August James Troendle M.D.	Chairman & CEO	1.65M	無	1956
Mr. Jesse J. Geiger BBA, CPA	President	945.08k	無	1974
Mr. Kevin M. Brady	CFO & Treasurer	690.48k	1.64M	1975
Ms. Susan E. Burwig BSN, MA	Executive Vice President of Operations	1.12M	1.47M	1963
Mr. Stephen P. Ewald J.D.	Chief Compliance Officer, General Counsel & Corporate Secretary	914.64k	3.2M	1969
Brandon Ebken	Chief Information Officer	無	無	無
Ms. Lauren Morris	Associate Director of Investors Relations	無	無	無
Mr. Todd Meyers	Vice President of Business Development & Marketing	無	無	無
John T. Wynne MBA	Senior Vice President of Commercial Operations & Clinical Pharmacology Unit	無	無	無
Mr. Reinilde Heyrman M.D.	Chief Medical Officer of Medical Department	無	無	1961

截止 2023年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

公司管治

截至 2024年4月1日 止，Medpace Holdings, Inc. 的 ISS 管治質素評分為 7。 Pillar 分數正在審核中：4；董事會：10；股東權利：8；現金賠償：5。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。